Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " September 12, 2007":" October 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Bioequivalency Study of Zidovudine Under Fasting Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
2 Completed Bioequivalency Study of Zidovudine Under Fed Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
3 Completed Pediatric Expanded Access Program-Oral Solution (0831-908)
Condition: HIV Infections
Intervention: Drug: MK0831
4 Completed A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
Condition: HIV Infections
Interventions: Drug: MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks;   Drug: Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks
5 Unknown  Pilot Study of the Impact of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Undetectable Plasma Virus
Condition: HIV Infections
Intervention: Drug: Raltegravir (MK-0518)
6 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
7 Completed Double Protease Inhibitor to Darunavir Switch Study
Condition: HIV Infections
Intervention: Drug: Darunavir ritonavir
8 Completed Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Condition: HIV Infections
Intervention: Biological: Biologically active recombinant Tat protein
9 Completed
Has Results
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Darunavir (DRV/r);   Drug: continue on current dual boosted PI
10 Completed The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
Condition: HIV Infections
Interventions: Drug: nevirapine;   Drug: atazanavir/ritonavir
11 Unknown  A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Condition: HIV Infections
Intervention: Biological: EP1090
12 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
Condition: HIV Infections
Interventions: Drug: Dolutegravir;   Drug: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Rilpivirine;   Drug: Lamivudine;   Drug: tenofovir;   Drug: Emtricitabine;   Drug: Abacavir
13 Terminated HIV - Monotherapy in Switzerland (MOST-ch)
Condition: HIV Infections
Interventions: Drug: Lopinavir-Monotherapy;   Drug: HAART
14 Completed Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
Condition: HIV Infections
Interventions: Drug: tenofovir + emtricitabine + efavirenz;   Drug: tenofovir + emtricitabine + lopinavir-ritonavir;   Drug: tenofovir + emtricitabine + atazanavir-ritonavir
15 Completed
Has Results
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Conditions: HIV Infections;   HIV-1
Interventions: Drug: TMC278;   Drug: efavirenz
16 Completed
Has Results
Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients
Condition: HIV Infections
Intervention:
17 Unknown  Improving Provider Counseling Interventions in HIV Practice
Condition: HIV Infections
Intervention: Behavioral: Stage based counseling
18 Completed
Has Results
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Tipranavir;   Drug: Etravirine;   Drug: Maraviroc
19 Completed TMC 125 Blood Levels Study
Condition: HIV Infections
Interventions: Drug: TMC125 once daily;   Drug: TMC125 twice daily
20 Completed
Has Results
Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.